Review of levetiracetam, with a focus on the extended release formulation, as adjuvant therapy in controlling partial-onset seizures

Levetiracetam is a second-generation antiepileptic drug (AED) with a unique chemical structure and mechanism of action. The extended release formulation of levetiracetam (Keppra XR(™); UCB Pharma) was recently approved by the Food and Drug Administration for adjunctive therapy in the treatment of pa...

Descripción completa

Detalles Bibliográficos
Autores principales: Ulloa, Carol M, Towfigh, Allen, Safdieh, Joseph
Formato: Texto
Lenguaje:English
Publicado: Dove Medical Press 2009
Materias:
Expert Opinion
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747386/
https://www.ncbi.nlm.nih.gov/pubmed/19777068

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2747386/
https://www.ncbi.nlm.nih.gov/pubmed/19777068

Ejemplares similares